Stay updated on Avelumab First-line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab First-line NSCLC Clinical Trial page.

Latest updates to the Avelumab First-line NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe revision history adds a new Revision: v3.5.4 entry, updating the page's version lineage by replacing the previous v3.5.3 entry.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.5.3, has been added to the study's record history, representing an updated version of the record. The previous revision, v3.5.2, has been removed from the history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page history now shows revision v3.5.2, replacing the previous v3.5.0. This is a minor metadata update and does not change study data, eligibility, or user-facing content.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.5.0 was added and the previous revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check66 days agoChange DetectedA new site revision entry (v3.4.3) was added to the history, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.4.2 was added to the history. The government-funding operating-status notice was removed.SummaryDifference0.4%

Stay in the know with updates to Avelumab First-line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab First-line NSCLC Clinical Trial page.